US Patent Issued to Miltenyi Biotec on May 19 for "Compositions and methods for treating cancer expressing CD90 and CD326" (German Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,645, issued on May 19, was assigned to Miltenyi Biotec B.V. & Co. KG (Bergisch Gladbach, Germany).

"Compositions and methods for treating cancer expressing CD90 and CD326" was invented by Christoph Herbel (Bergisch Gladbach, Germany), Dominik Eckardt (Bergisch Gladbach, Germany), Vera Dittmer (Bergisch Gladbach, Germany), Manuel Martinez-Osuna (Bergisch Gladbach, Germany), Jutta Kollet (Bergisch Gladbach, Germany), Thorsten Olaf Hardt (Bergisch Gladbach, Germany) and Andreas Bosio (Bergisch Gladbach, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a combination comprising a) an antigen binding domain specific for...